Latest / In Good Company with Nicolai Tangen
Pfizer CEO: Transforming Drug Discovery, Lessons from China and Leading with Optimism
Nicolai Tangen meets Pfizer CEO Albert Bourla for a wide-ranging conversation on leadership, science, and the future of global healthcare. Bourla reflects on leading Pfizer through the COVID-19 vaccine breakthrough and how it transformed the company. The discussion also dives into Pfizer’s strategic shift toward innovative medicine, including major investments in oncology and obesity, and the high-stakes decisions behind multibillion-dollar acquisitions.
Looking ahead, the conversation explores how artificial intelligence is set to transform drug discovery, clinical trials, and the broader…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.